Latest Ratings for HCAT
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Piper Sandler | Maintains | Overweight | |
| Mar 2022 | Raymond James | Maintains | Strong Buy | |
| Mar 2022 | Canaccord Genuity | Maintains | Buy |
View More Analyst Ratings for HCAT
View the Latest Analyst Ratings
Read the full story on Benzinga.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
